Leo Ehrlich
Patrimonio netto: 4 334 $ in data 30/09/2026
Patrimonio netto: 4 334 $ in data 30/09/2026
Mr. Leo Ehrlich, CPA, is a Chairman, CEO, Chief Financial Officer & Secretary at Innovation Pharmaceuticals, Inc. Mr. Ehrlich was previously employed as a Chief Financial Officer by Cellceutix Pharma, Inc., a Chief Financial Officer by NanoViricides, Inc. /Old/, a President, CEO, COO, CFO, Secretary & Director by StatSure Diagnostic Systems, Inc., and a Chief Financial Officer & Director by NanoViricides, Inc. He received his undergraduate degree from Baruch College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/09/2023 | 4.333.936 ( -.--% ) | 4 334 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INNOVATION PHARMACEUTICALS INC. | Amministratore Delegato | 05/11/2010 |
| Società | Posizione | Fine |
|---|---|---|
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Direttore Finanziario/CFO | 06/12/2007 |
| NANOVIRICIDES, INC. | Direttore Finanziario/CFO | 16/05/2007 |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direttore Finanziario/CFO | 01/05/2007 |
| STATSURE DIAGNOSTIC SYSTEMS, INC. | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
StatSure Diagnostic Systems, Inc.
StatSure Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical specimen collection devices for the rapid tests of infectious diseases | Health Technology |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
NanoViricides, Inc.
NanoViricides, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes anti-viral therapeutics | Health Technology |
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Health Technology |
Innovation Pharmaceuticals, Inc.
Innovation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale